|
Epigenomics AG - Company Profile Snapshot
| Company Profile: |
Epigenomics AG |
| Ticker: |
ECX |
| Exchanges: |
FRA |
| 2008 Sales: |
2,586,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
GERMANY |
| Employees: |
90 |
Business Description
Epigenomics AG. The Group's principal activity is to conduct molecular diagnosis for the early detection and treatment of cancer and other complex diseases. The Group's products are based on DNA methylation, which are aimed at making early detection and treatment easier, more accurate and more convenient for the patient. The Group compares patient's cells against healthy and sick reference samples, which enables an exact diagnosis of disease at a very early stage and provides physicians with essential information to help guide the appropriate therapy. The group operates in Europe and North America.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
